2009
DOI: 10.1177/1479972308098159
|View full text |Cite
|
Sign up to set email alerts
|

Health-related quality of life measurement in cystic fibrosis: advances and limitations

Abstract: Health-related quality of life (HRQoL) measurement in cystic fibrosis (CF) allows the inclusion of the patient's perspective in research and clinical practice. HRQoL scales have been used for many purposes and this review focuses on how HRQoL measurement has been implemented in CF research and care. Specifically, the review considers 1) the instruments used to measure HRQoL, 2) the factors that influence how people report HRQoL, 3) the monitoring of HRQoL in clinical practice, 4) HRQoL as an outcome measure in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
23
0
3

Year Published

2010
2010
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(28 citation statements)
references
References 110 publications
2
23
0
3
Order By: Relevance
“…The high HRQoL scores reported by CF patients are a common finding in many studies (17). We found that the differences in CFQ domain scores were influenced by age.…”
Section: Discussionsupporting
confidence: 49%
“…The high HRQoL scores reported by CF patients are a common finding in many studies (17). We found that the differences in CFQ domain scores were influenced by age.…”
Section: Discussionsupporting
confidence: 49%
“…Therefore, HRQOL measurement can provide added value because it can supply information not captured by other outcome measures. HRQOL may be informative not only as an efficacy measure, but it also potentially reflects safety issues, and for these reasons HRQOL is becoming important in labeling claims 6, 7.…”
Section: Introductionmentioning
confidence: 99%
“…physical, social and psychological functioning, respiratory symptoms, treatment burden and body image)' . 210 To populate a model of CF and CFRD that allows us to evaluate the clinical effectiveness and cost-effectiveness of screening for CFRD, we ideally need: ■ Data on QoL over the lifetime of CF in patients who do not develop CFRD. We would expect a decline in QoL over the decades.…”
Section: Quality-of-life Studies In Cystic Fibrosis and Cystic Fibrosmentioning
confidence: 99%